Abingworth LLP Exicure, Inc. Call Options Transaction History
Abingworth LLP
- $301 Million
- Q4 2022
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding XCUR
# of Institutions
16Shares Held
766KCall Options Held
0Put Options Held
0-
Carlyle Group Inc. Washington, DC282KShares$833,6420.01% of portfolio
-
Geode Capital Management, LLC Boston, MA56.5KShares$167,2960.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA46KShares$136,1650.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA40.1KShares$118,6750.0% of portfolio
-
Ubs Group Ag17.3KShares$51,2400.0% of portfolio
About EXICURE, INC.
- Ticker XCUR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 4,962,580
- Market Cap $14.7M
- Description
- Exicure, Inc., a biotechnology company, develops therapies for neurological disorders and hair loss based on its proprietary spherical nucleic acid (SNA) technology. Its lead program candidate includes SCN9A that is in preclinical studies for neuropathic and chronic pain. The company has a collaboration, option, and license agreement with AbbVie...